SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : COB Columbia Laboratories -- Ignore unavailable to you. Want to Upgrade?

To: wolfdog2 who wrote (585)9/8/1999 10:57:00 PM
From: sally bananas  Respond to of 634
 
Thanks for posting the Townsend article. I wish it could be updated to reflect that Aeres Serono is marketing Crinone now and Solvay is marketing Prometrium in the US. Can hardly wait to see which company is chosen to market Crinone 4%---the sooner the better.



To: wolfdog2 who wrote (585)9/13/1999 9:04:00 AM
From: wolfdog2  Read Replies (1) | Respond to of 634
 
More insider buying. According to InsiderTrader a director purchased 4500 shares of COB in August at $6.08. If anyone has any information as to the identity of the director, please post it.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News